0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > M-CSF

M-CSF

M-CSF Molecule Information

Name:Macrophage Colony Stimulating Factor 1
Target Synonym:CSF-1;M-CSF;MCSF;Processed macrophage colony-stimulating factor 1
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:4
Lastest Research Phase:Phase ?

M-CSF Protein Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
Cat. No. Species Product Description Structure Purity Feature
MCF-H82E6 Human Biotinylated Human M-CSF / CSF-1 Protein, His,Avitag™
MCF-H82E6-structure
MCF-H82E6-sds
MCF-H82E6-elisa_1
MCF-H5247 Human Human M-CSF / CSF-1 Protein, His Tag
MCF-H5247-structure
MCF-H5247-sds
MCF-H5247-elisa_1

M-CSF Molecule Synonym Name

M-CSF,CSF-1,Lanimostim

M-CSF Molecule Background

The colony stimulating factor 1 (CSF1), also known as macrophage colony-stimulating factor (M-CSF), is a secreted cytokine which influences hematopoietic stem cells to differentiate into macrophages or other related cell types. Eukaryotic cells also produce M-CSF in order to combat intercellular viral infection. It is one of the three experimentally described colony-stimulating factors. M-CSF binds to the colony stimulating factor 1 receptor. Macrophage colony-stimulating factor has been shown to interact with PIK3R2. M-CSF (or CSF-1) is a hematopoietic growth factor that is involved in the proliferation, differentiation, and survival of monocytes, macrophages, and bone marrow progenitor cells. Locally produced M-CSF in the vessel wall contributes to the development and progression of atherosclerosis.

M-CSF References

M-CSF Related Molecule

M-CSF Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Lacnotuzumab MCS-110 Phase Ⅱ Novartis Bone metastases from solid tumors, Prostate cancer, Breast cancer, Solid tumours, Tenosynovial giant cell tumor (TGCT), Pigmented villonodular synovitis Details
Granulocyte-macrophage colony stimulating factor (Otsuka Pharmaceutical) Phase Ⅰ Otsuka Immunostimulant Details
Sargramostim therapy (Innoventus Project) Phase Ⅰ Innoventus Project Periodontitis Details
PD-360324 PD-360324; PD-0360324 Phase Ⅱ Pfizer Solid tumours Details

This web search service is supported by Google Inc.

totop